Literature DB >> 26946414

Erratum to: Soluble epoxide hydrolase inhibitor 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea attenuates bleomycin-induced pulmonary fibrosis in mice.

Yong Zhou1, Jun Yang2, Guo-Ying Sun1, Tian Liu1, Jia-Xi Duan1, Hui-Fang Zhou1, Kin Sing Lee2, Bruce D Hammock2, Xiang Fang3, Jian-Xin Jiang4, Cha-Xiang Guan5.   

Abstract

Entities:  

Year:  2016        PMID： 26946414     DOI： 10.1007/s00441-016-2379-9

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN： 0302-766X            Impact factor:   5.249


× No keyword cloud information.
  2 in total

1.  COX-2/sEH Dual Inhibitor PTUPB Alleviates CCl 4 -Induced Liver Fibrosis and Portal Hypertension.

Authors:  Zhifeng Zhao; Chihao Zhang; Jiayun Lin; Lei Zheng; Hongjie Li; Xiaoliang Qi; Haizhong Huo; Xiaolou Lou; Bruce D Hammock; Sung Hee Hwang; Yongyang Bao; Meng Luo
Journal:  Front Med (Lausanne)       Date:  2021-12-23

2.  Pharmacokinetics, pharmacodynamics and adverse event profile of GSK2256294, a novel soluble epoxide hydrolase inhibitor.

Authors:  Aili L Lazaar; Lucy Yang; Rebecca L Boardley; Navin S Goyal; Jonathan Robertson; Sandra J Baldwin; David E Newby; Ian B Wilkinson; Ruth Tal-Singer; Ruth J Mayer; Joseph Cheriyan
Journal:  Br J Clin Pharmacol       Date:  2016-01-17       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.